Concourse Financial Group Securities’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-500
Closed -$32K – 2348
2020
Q3
$31K Hold
500
– – ﹤0.01% 1224
2020
Q2
$31K Hold
500
– – ﹤0.01% 1133
2020
Q1
$27K Hold
500
– – ﹤0.01% 1125
2019
Q4
$32K Hold
500
– – ﹤0.01% 1105
2019
Q3
$28K Sell
500
-2,090
-81% -$120K 0.01% 834
2019
Q2
$152K Buy
2,590
+45
+2% +$2.6K 0.02% 548
2019
Q1
$154K Buy
2,545
+2,045
+409% +$121K 0.02% 565
2018
Q4
$27K Hold
500
– – ﹤0.01% 1021
2018
Q3
$32K Buy
+500
New +$31.2K 0.01% 698

Other funds holding PPH

Concourse Financial Group Securities's PPH Position: Q4 2020 in Review

Concourse Financial Group Securities sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2020, closing a stake of 500 shares — an estimated $32K sold.

Concourse Financial Group Securities first reported a position in PPH in Q3 2018 and held it in 9 quarters. The position peaked at $154K in Q1 2019. 49 funds tracked by Wall St. Rank hold PPH as of Q4 2020.

  • Concourse Financial Group Securities reported no remaining VanEck Pharmaceutical ETF position as of Q4 2020 after selling out during the quarter.
  • Concourse Financial Group Securities sold 500 VanEck Pharmaceutical ETF shares in Q4 2020, an estimated $32K.
  • Concourse Financial Group Securities first reported a position in VanEck Pharmaceutical ETF in Q3 2018 and held it in 9 quarters.
  • Concourse Financial Group Securities's VanEck Pharmaceutical ETF position peaked at $154K in Q1 2019.
  • 49 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2020.

Based on Concourse Financial Group Securities's 13F filing for Q4 2020, filed 2 Feb 2021.